On Jan. 9, Northfield Laboratories
- In December, the company reported preliminary top-line data from its pivotal phase 3 trauma trial assessing the efficacy and safety of PolyHeme. The trial was a failure and the stock lost roughly two-thirds of its value.
- Based on the preliminary results, the company has decided to proceed anyway. It will submit a Biologics License Application to the FDA to get approval to market PolyHeme in the U.S.
- The company is spending its cash resources at a rate of around $28 million per year and believes its existing capital resources will be sufficient to carry its operations until submission of a BLA to the FDA, for approximately 21 to 24 months.
(Figures in thousands, except per-share data)
Income Statement Highlights
|
Q2 2007 |
Q2 2006 |
Change |
|
|---|---|---|---|
|
Sales |
$0.0 |
$0.0 |
N/A |
|
Net Profit |
($7,603) |
($6,269) |
N/A |
|
EPS |
($0.28) |
($0.23) |
N/A |
|
Diluted Shares |
26,800 |
26,759 |
0.2% |
Get back to basics with a look at the income statement.
Margin Checkup
Margins are not a relevant metric at this time, given the lack of revenue.
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q2 2007 |
Q2 2006 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$51,860 |
$86,119 |
(40.0%) |
|
Accounts Rec. |
No Data |
No Data |
No Data |
|
Inventory |
No Data |
No Data |
No Data |
|
Liabilities |
Q2 2007 |
Q2 2006 |
Change |
|---|---|---|---|
|
Accounts Payable |
$3,641 |
$2,426 |
50.1% |
|
Long-Term Debt |
$0.0 |
$0.0 |
N/A |
Learn the ways of the balance sheet.
Cash Flow Highlights
A statement of cash flows was not provided in the press release.
Find out why Fools always follow the money.
Related Companies:
-
Biopure
(NASDAQ:BPUR)
Related Foolishness:
Forty Motley Fool CAPS All-Stars pick Northfield to outperform the market. Nine say it will underperform. Where do you stand? Join more than 19,000 fellow investors in the Fool's new stock-rating service and let your voice be heard.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
